Active Biotech AB
ACTI
Company Profile
Business description
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.
Contact
Scheelevagen 22
Lund223 63
SWET: +46 46192000
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
7
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,053.20 | 142.30 | -1.74% |
| CAC 40 | 7,790.71 | 125.37 | -1.58% |
| DAX 40 | 22,163.49 | 298.03 | -1.33% |
| Dow JONES (US) | 41,593.90 | 10.00 | 0.02% |
| FTSE 100 | 8,582.81 | 76.04 | -0.88% |
| HKSE | 23,119.58 | 307.02 | -1.31% |
| NASDAQ | 17,053.02 | 269.97 | -1.56% |
| Nikkei 225 | 35,617.56 | 1,502.77 | -4.05% |
| NZX 50 Index | 12,270.00 | 17.46 | -0.14% |
| S&P 500 | 5,543.21 | 37.73 | -0.68% |
| S&P/ASX 200 | 7,843.40 | 138.60 | -1.74% |
| SSE Composite Index | 3,335.75 | 15.56 | -0.46% |